Axel Rominger - Concepedia

Author

Axel Rominger

Ludwig-Maximilians-Universität München ORCID

Also Known As

A Rominger, A. O. Rominger, A. Rominger, Andrew Rominger, Annie H Rominger, Axel Rominger, H Schulze-Koops, John Seibyl, Kamilov, Ulugbek S., Kazunari Ishii

624

Publications

11.9K

Citations

H-Index

133

Concepts

All Affiliations

Ludwig-Maximilians-Universität München University Hospital of Bern University of Bern German Center for Neurodegenerative Diseases Munich Cluster for Systems Neurology

About

Axel Rominger is an author at Ludwig-Maximilians-Universität München specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	37	2K
2	Health Sciences	15	16	846
3	Engineering	10	10	450
4	Public Health	4	4	254
5	Arts	1	1	12

Axel Rominger

196

Publications

9.7K

Citations

H-Index

Page 1

	Year	Citations
<scp>sTREM</scp> 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers Marc Suárez‐Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, EMBO Molecular Medicine ImmunologyNeurochemical BiomarkersSocial SciencesNeuroinflammationCsf Levels	2016	503
Real versus imagined locomotion: A [18F]-FDG PET-fMRI comparison Christian la Fougère, Andreas Zwergal, Axel Rominger, NeuroImage Real VersusBrain MappingNeuroimagingNeuroscienceBrain Organization	2009	400
<sup>18</sup>F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease Axel Rominger, Tobias Saam, Sarah Wolpers, Journal of Nuclear Medicine	2009	352
Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard George Prenosil, Hasan Sari, Markus Fürstner, Journal of Nuclear Medicine	2021	307
Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT Ian Alberts, Jan-Niklas Hünermund, George Prenosil, European Journal of Nuclear Medicine and Molecular Imaging	2021	273
The <scp>FTD</scp> ‐like syndrome causing <scp>TREM</scp> 2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism Gernot Kleinberger, Matthias Brendel, Éva Mracskó, The EMBO Journal	2017	270
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases Xianyuan Xiang, Karin Wind, Thomas Wiedemann, Science Translational Medicine	2021	245
Preliminary experience with dosimetry, response and patient reported outcome after 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer Wolfgang P. Fendler, Svenja Reinhardt, Harun Ilhan, Oncotarget	2016	220
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial Richard Dodel, Axel Rominger, Peter Bartenstein, The Lancet Neurology Geriatric NeurologyAlzheimer's DiseaseMedicineDementiaIntravenous Immunoglobulin	2013	183
In Vivo Imaging of Macrophage Activity in the Coronary Arteries Using <sup>68</sup>Ga-DOTATATE PET/CT: Correlation with Coronary Calcium Burden and Risk Factors Axel Rominger, Tobias Saam, Eva Vogl, Journal of Nuclear Medicine	2010	155

Page 1